Page results
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information
-
Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
While you're pregnant you will have a nominated professional lead which will be a midwife or an obstetrician.
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
File results
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0069 - Operations waits for under-18s
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2023/0103 - Genetic Haemochromatosis patients